Especialista en Endocrinología y Maestría en Ciencias de la Salud.
Hospital General de México.
Cédula 4795309.
Especialista en Cardiología.
Hospital de Cardiología, Centro Médico Nacional Siglo XXI.
Cédula 4011182.
Mediavilla BJJ, et al. Complicaciones de la diabetes mellitus. Diagnóstico y tratamiento. SEMERGEN: 2001. 27:132-145.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.
Holman RR, et al. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008 Oct 9;359(15):1577-89.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
Testa R, et al. The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications. Nutrients 2017, 9, 437.
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008;358:2560-72.
Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008;358:254559.
Duckworth W, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009;360:129-39.
Martín-Timón I, et al. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes 2014 August 15; 5(4): 444-470.
Verma S, et al. Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials. Diabetes Obes Metab. 2019;21: 1745–1751.
Lee K-S, et al. Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement. Int J Heart Fail. 2023 Jan;5(1):1-20
Vaag AA. Glycemic Control and Prevention of Microvascular and Macrovascular Disease in the Steno 2 Study. Endocr Pract. 2006 Jan-Feb;12 Suppl 1:89-92.